Almanac Health Raises $10M in Seed Round
Almanac Health, a Boston, MA–based unified clinical AI platform for clinical decision support, has raised $10 million in Seed funding.
The round was led by F-Prime, with participation from General Catalyst and Lightspeed Venture Partners.
F-Prime is a global venture capital firm that invests in healthcare and technology companies. With decades of investing experience, it operates across stages from early venture to growth, while maintaining a strong emphasis on deep science, including biotechnology, therapeutics, and data-driven healthcare, alongside enterprise software and fintech. The firm manages $4.8 billion in assets under management (AUM).
The company will use the funding to expand its team across clinical medicine, AI research, and health systems infrastructure, while advancing R&D focused on privacy, reliability, and rigorous clinical validation.
Founded by Cyril Zakka, Almanac Health is a clinical AI platform that delivers specialist-grade knowledge to clinicians at the point of care. It provides evidence-based clinical decision support across medical specialties, free from pharmaceutical advertising, and governed by institutional controls. Almanac Health integrates with existing EHR systems and is clinically validated through peer-reviewed research.
Funding Details
Company: Almanac Health, Inc.
Raised: $10.0M
Round: Seed
Funding Date: April 2026
Lead Investor: F-Prime
Additional Investors: General Catalyst, Lightspeed Venture Partners
Company Website: https://almanac.chat/
Software Category: Healthcare AI / Clinical Decision Support